Status:

COMPLETED

Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients

Lead Sponsor:

Novartis Pharmaceuticals

Conditions:

Renal Transplantation

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

This study will assess the association of an initially intensified dosing regimen of enteric-coated mycophenolate sodium (EC-MPS) during the first 6 weeks post renal transplantation with acute rejecti...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • Recipients of de novo cadaveric, living unrelated or living related kidney transplants
  • Females capable of becoming pregnant must have a negative serum pregnancy test within 7 days prior to or at baseline, and are required to practice an approved method of birth control for the duration of the study and for a period of 6 weeks following discontinuation of study medication, even where there has been a history of infertility.
  • Patients who are willing and able to participate in the study and from whom written informed consent has been obtained.
  • Exclusion criteria
  • More than one previous renal transplantation
  • Graft loss due to immunological reasons in the first year after transplantation (in case of secondary transplantation)
  • Multi-organ recipients (e.g., kidney and pancreas) or previous transplant with any other organ, different from kidney
  • Patients receiving a kidney from a non-heart beating donor
  • Patients who are recipients of A-B-O incompatible transplants
  • Other protocol-defined inclusion/exclusion criteria may apply

Exclusion

    Key Trial Info

    Start Date :

    June 1 2006

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2008

    Estimated Enrollment :

    128 Patients enrolled

    Trial Details

    Trial ID

    NCT00369278

    Start Date

    June 1 2006

    End Date

    December 1 2008

    Last Update

    March 29 2011

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Novartis Investigational Site

    Various Cities, Germany